Fatal Familial Insomnia (FFI) is an autosomal dominant prion disease,
characterized by prominent degeneration of the thalamus and involving
impaired control of the sleep-wake cycle and of autonomic and endocrin
e functions. Profound alterations in the sleep-wake cycle consist of p
rogressive decrease or complete absence of sleep activity and loss of
any intrinsic cyclic organization of residual sleep. Unbalanced sympat
hergic activation with preserved parasympathetic drive, associated wit
h chronic secondary hypertension and loss of the physiological nocturn
al decrease in blood pressure constitute the characteristic autonomic
changes. Neuroendocrine studies document hypercortisolism with abnorma
l feed-back suppression of adrenocorticotrophic hormone, constantly el
evated catecholamine levels and abnormal secretory patterns of growth
hormone, prolactin and melatonin. Advanced stages of the disease are i
nvariably characterized by the disappearance of any circadian autonomi
c and neuroendocrine rhythmicity. FFI represents a model disease empha
sizing the correlations among the different sleep, autonomic and neuro
endocrine functions. Clinico-pathological correlations demonstrate the
role of the thalamus as an integrative neural structure placed betwee
n the limbic system and the hypothalamus and controlling the homeostat
ic balance of the organism